Vonoprazan Fumarate
규격
1260141-27-2CAS 번호
(E)-but-2-enedioic acid;1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamineIUPAC 명칭
C21H20FN3O6S화학식
461.5 g/mol분자량
Vonoprazan Fumarate; 1260141-27-2; TAK-438; 881681-01-2; Vonoprazan fumurate; 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate; TAK 438; TAK438; 1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-, 2-butenedioate (1:1); TAK-438 monofumarate; Vonoprazan Fumarate (TAK-438); 2098974-13-9; MFCD18633280; VOQUEZNA; (E)-but-2-enedioic acid;1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine; 1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine xfumarate; Vonoprazan monofumarate; 4QW3X4AMLB; Vonoprazan fumarate [USAN]; takecab; C21H20FN3O6S; 1H-pyrrole-3-methanamine, 5-(2-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-, (2E)-2-butenedioate (1:1); Vonoprazan monofumurate; Voquezna (TN); (2E)-but-2-enedioic acid; {[5-(2-fluorophenyl)-1-(pyridine-3-sulfonyl)-1H-pyrrol-3-yl]methyl}(methyl)amine; 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate; 1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-, (2E)-2-butenedioate (1:1); 5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine (2E)-2-butenedioate (1:1); TAK 438; TAK 438 monofumarate; Takecab; Voci; Takecab (TN); 5-(2-Fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine (2E)-2-butenedioate; SCHEMBL194394; orb1305537; orb1306422; orb1940457; CHEMBL2064032; SCHEMBL29379818; SCHEMBL29407867; VONOPRAZAN FUMARATE [MI]; Vonoprazan fumarate (JAN/USAN); EX-A097; VONOPRAZAN FUMARATE [JAN]; ROGSHYHKHPCCJW-WLHGVMLRSA-N; GLXC-20553; GLXC-90373; HMS5086C05; EX-A4001; TAK-438?; ARD162557; EBC-71028; s8016; VONOPRAZAN FUMARATE [WHO-DD]; AKOS027251052; CCG-269350; 1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine monofumarate; AC-29287; AC-29309; DA-78911; DS-12234; FF102206; FT102406; LS-14849; SY122312; CS-0164592; SW220126-1; D10466; T21254; EN300-21682776; F863793; Q25104163; 1-[5-(2-fluorophenyl)-1-(3-pyridylsulfonyl)pyrrol-3-yl]-N-methyl-methanamine;fumaric acid; 1-[5-(2-fluorophenyl)-1-(pyridine-3-sulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate; 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate? (Vonoprazan Impurity pound(c); 1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanaminexfumarate; 3-{[2-(2-fluorophenyl)-4-[(methylamino)methyl]pyrrol-1-yl]dioxo-|E6-sulfanyl}pyridine fumarate; 5-(2-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-Pyrrole-3-methanamine (2E)-2-butenedioate (1:1); Vonoprazan Fumarate (Micronized)동의어
Vonoprazan Fumarate 함유 제품
보주캡정10밀리그램(보노프라잔푸마르산염)보주캡정20밀리그램(보노프라잔푸마르산염)보노티정10밀리그램(보노프라잔푸마르산염)브이테라잔정20밀리그램(보노프라잔푸마르산염)보노스카이정20밀리그램(보노프라잔푸마르산염)보노스카이정10밀리그램(보노프라잔푸마르산염)보노비정20밀리그램(보노프라잔푸마르산염)보노비정10밀리그램(보노프라잔푸마르산염)보프캡정20밀리그램(보노프라잔푸마르산염)보프캡정10밀리그램(보노프라잔푸마르산염)활캡정20밀리그램(보노프라잔푸마르산염)활캡정10밀리그램(보노프라잔푸마르산염)
1/10 페이지
Vonoprazan Fumarate 판매 기업
(주
(주)동구바이오제약Republic of Korea동국
동국제약(주)Republic of Korea(주
(주)유한양행Republic of Korea한림
한림제약(주)Republic of Korea삼진
삼진제약(주)Republic of Korea(주
(주)보령Republic of Korea일양
일양약품(주)Republic of Korea제이
제이더블유중외제약(주)Republic of Korea아주
아주약품(주)Republic of Korea유니
유니메드제약(주)Republic of Korea1/7 페이지